As of Mar 27
| +1.05 / +2.76%|
The 3 analysts offering 12-month price forecasts for Natus Medical Inc have a median target of 42.00, with a high estimate of 42.00 and a low estimate of 40.00. The median estimate represents a +7.33% increase from the last price of 39.13.
The current consensus among 4 polled investment analysts is to Buy stock in Natus Medical Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.